Career Development Award

Organization
American Society of Clinical Oncology (ASCO)
Type
Foundation
Application or LOI Due Date
09-24-2020
Brief Description

The Career Development Award (CDA) provides research funding to clinical investigators, who have received their initial faculty appointment, as they work to establish an independent clinical cancer research program. This research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Proposals with a predominant focus on in vitro or animal studies (even if clinically relevant) are not allowed. Applications in all areas of cancer research are accepted from U.S. and international applicants.

The CDA is a three-year grant totaling $200,000 that supports personnel and/or research expenses, and travel to attend the Conquer Cancer Grants and Awards Ceremony at the ASCO Annual Meeting.

Eligibility

Applicants must meet the following criteria to qualify for a CDA:

  • Be a physician (MD, DO of international equivalent) working in any country.
  • Be in the first to third year of a full-time primary faculty appointment in a clinical department at an academic medical institution at the time of grant submission. Faculty appointment may begin with the entry-level faculty position within the applicant’s institution (i.e., Instructor/Lecturer, Assistant Professor, Assistant Member). 
  • Have a valid, active medical license in the country where the research will be conducted at the time of application.
  • Have completed productive postdoctoral research and demonstrated the ability to undertake independent investigator-initiated clinical research.
  • Be an ASCO Member or have submitted a membership application with the grant application. To apply for membership, or to renew an existing membership, please visit http://www.asco.org/membership.
  • Be able to commit more than 50% of full-time effort in research (applies to total research, not just the proposed project) during the award period.
  • Have a mentor from the sponsoring institution who must provide a letter of support. If the mentor is not an ASCO Member, a supporting letter from an ASCO Member from the sponsoring institution must be included.
  • Eligible physicians are allowed to hold only one grant from Conquer Cancer at a time.
  • Applicants who hold concurrent career development awards (e.g., K23, K08, or any other type of career development award) must notify Conquer Cancer before they submit an application. Past recipients of training fellowships (e.g., Young Investigator Award or an F32 grant) are eligible. Applicants with institutional KL2/K12 grants are eligible to apply, but must notify Conquer Cancer if they are currently funded by such an award. If there are questions regarding eligibility associated with previous and current grants received, applicants are encouraged to send an email to grants@conquer.org for clarification.
  • Be up-to-date and in compliance with all requirements (e.g., progress reports, final reports, budget summaries, IRB approvals, etc.) of any past grants received from Conquer Cancer.

Funding Available

The number of CDA grants in each funding cycle is not predetermined by Conquer Cancer.  Awards are given based on individual merit and availability of funds.

For 2021, funding is available for the CDA (Request for Proposals for all areas) and CDA in Palliative and Supportive Care in Oncology (Request for Proposals).

Application Instructions

All application materials must be in English and must be submitted through the Application Portal. Paper applications or applications sent by e-mail or fax will not be accepted.